Akebia Therapeutics Inc. buy Leerink Partnrs
Start price
30.04.25
/
50%
€2.11
Target price
30.04.26
-
Performance (%)
-32.73%
Price
12.12.25
€1.38
Summary
This prediction is currently active. Massive losses of -32.73% have been the result for the BUY prediction by Leerink_Partnrs. This prediction currently runs until 30.04.26. The prediction end date can be changed by Leerink_Partnrs at any time. Leerink_Partnrs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | 5.327% | 5.327% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Leerink_Partnrs for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ratings data for AKBA provided by MarketBeat